Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Porter

Showing results (111-120 of 1,141) with videos related to

Pageof 115
Sort By:
Expert Opinion on Drug Delivery|January 24, 2013
An update on pharmaceutical film coating for drug deliveryLinda A Felton, Stuart C Porter
Experimental Biology and Medicine (Maywood, N.J.)|November 25, 2017
Preclinical biomarker qualificationJohn-Michael Sauer, Amy C Porter,
Endocrinology|October 1, 1979
Circulating luteinizing hormone and prolactin concentrations in intact or castrated male rats treated with 5-hydroxytryptamineN S Pilotte, J C Porter
Pediatric Emergency Care|June 2, 2011
A content analysis of parents' written communication of needs and expectations for emergency care of their childrenEric Christopher Hoppa, Stephen C Porter
Hormone Research|January 1, 1985
Involvement of hypothalamic dopamine in the regulation of prolactin secretionM J Reymond, J C Porter
Biochemical and Biophysical Research Communications|March 30, 1988
Extraction of phosphorylated sperm specific histone H1 from sea urchin eggs: analysis of phosphopeptide mapsD C Porter, V D Vacquier
JAMA Neurology|September 12, 2022
Racial and Ethnic Equity in Neuromuscular Care-Time for Our Action to Live Up to PotentialNeil C Porter, Lewis B Morgenstern
Drug and Chemical Toxicology|January 20, 1998
Overview of DOD activities in ecological risk assessmentJ E Whaley, R C Porter
Gene Therapy|August 24, 1999
Gene targeting is enhanced in human cells overexpressing hRAD51R J Yáñez, A C Porter
Mutation Research|October 6, 2000
Uracil incorporation into a gene targeting construct reduces the frequency of homologous and nonhomologous recombinants in human cellsR J Yáñez, A C Porter
Pageof 115

Showing results (111-120 of 1,141) with videos related to

Sort By:
Pageof 115
Expert Opinion on Drug Delivery|January 24, 2013
An update on pharmaceutical film coating for drug deliveryLinda A Felton, Stuart C Porter
Experimental Biology and Medicine (Maywood, N.J.)|November 25, 2017
Preclinical biomarker qualificationJohn-Michael Sauer, Amy C Porter,
Endocrinology|October 1, 1979
Circulating luteinizing hormone and prolactin concentrations in intact or castrated male rats treated with 5-hydroxytryptamineN S Pilotte, J C Porter
Pediatric Emergency Care|June 2, 2011
A content analysis of parents' written communication of needs and expectations for emergency care of their childrenEric Christopher Hoppa, Stephen C Porter
Hormone Research|January 1, 1985
Involvement of hypothalamic dopamine in the regulation of prolactin secretionM J Reymond, J C Porter
Biochemical and Biophysical Research Communications|March 30, 1988
Extraction of phosphorylated sperm specific histone H1 from sea urchin eggs: analysis of phosphopeptide mapsD C Porter, V D Vacquier
JAMA Neurology|September 12, 2022
Racial and Ethnic Equity in Neuromuscular Care-Time for Our Action to Live Up to PotentialNeil C Porter, Lewis B Morgenstern
Drug and Chemical Toxicology|January 20, 1998
Overview of DOD activities in ecological risk assessmentJ E Whaley, R C Porter
Gene Therapy|August 24, 1999
Gene targeting is enhanced in human cells overexpressing hRAD51R J Yáñez, A C Porter
Mutation Research|October 6, 2000
Uracil incorporation into a gene targeting construct reduces the frequency of homologous and nonhomologous recombinants in human cellsR J Yáñez, A C Porter
Pageof 115